Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain
- PMID: 14769905
- DOI: 10.1099/vir.0.19531-0
Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain
Abstract
Japanese encephalitis virus (JEV), a single-stranded positive-sense RNA virus of the family Flaviviridae, is the major cause of paediatric encephalitis in Asia. The high incidence of subclinical infections in Japanese encephalitis-endemic areas and subsequent evasion of encephalitis points to the development of immune responses against JEV. Humoral responses play a central role in protection against JEV; however, cell-mediated immune responses contributing to this end are not fully understood. The structural envelope (E) protein, the major inducer of neutralizing antibodies, is a poor target for T cells in natural JEV infections. The extent to which JEV non-structural proteins are targeted by T cells in subclinically infected healthy children would help to elucidate the role of cell-mediated immunity in protection against JEV as well as other flaviviral infections. The property of the Tat peptide of Human immunodeficiency virus to transduce proteins across cell membranes, facilitating intracellular protein delivery following exogenous addition to cultured cells, prompted us to express the four largest proteins of JEV, comprising 71 % of the JEV genome coding sequence, as Tat fusions for enumerating the frequencies of virus-specific CD4(+) and CD8(+) T cells in JEV-immune donors. At least two epitopes recognized by distinct HLA alleles were found on each of the non-structural proteins, with dominant antiviral Th1 T cell responses to the NS3 protein in nearly 96 % of the cohort. The data presented here show that non-structural proteins are frequently targeted by T cells in natural JEV infections and may be efficacious supplements for the predominantly antibody-eliciting E-based JEV vaccines.
Similar articles
-
Human T cell responses to Japanese encephalitis virus in health and disease.J Exp Med. 2016 Jun 27;213(7):1331-52. doi: 10.1084/jem.20151517. Epub 2016 May 30. J Exp Med. 2016. PMID: 27242166 Free PMC article. Clinical Trial.
-
Conserved amino acids 193-324 of non-structural protein 3 are a dominant source of peptide determinants for CD4+ and CD8+ T cells in a healthy Japanese encephalitis virus-endemic cohort.J Gen Virol. 2004 May;85(Pt 5):1131-1143. doi: 10.1099/vir.0.19698-0. J Gen Virol. 2004. PMID: 15105530
-
Screening for T cell-eliciting proteins of Japanese encephalitis virus in a healthy JE-endemic human cohort using recombinant baculovirus-infected insect cell preparations.Arch Virol. 2003 Aug;148(8):1569-91. doi: 10.1007/s00705-003-0118-5. Arch Virol. 2003. PMID: 12898332
-
Dengue fever virus and Japanese encephalitis virus synthetic peptides, with motifs to fit HLA class I haplotypes prevalent in human populations in endemic regions, can be used for application to skin Langerhans cells to prime antiviral CD8+ cytotoxic T cells (CTLs)--a novel approach to the protection of humans.Virus Genes. 1994 Sep;9(1):33-45. doi: 10.1007/BF01703433. Virus Genes. 1994. PMID: 7871759 Review.
-
Japanese encephalitis virus: Associated immune response and recent progress in vaccine development.Microb Pathog. 2019 Nov;136:103678. doi: 10.1016/j.micpath.2019.103678. Epub 2019 Aug 19. Microb Pathog. 2019. PMID: 31437579 Review.
Cited by
-
Japanese Encephalitis Virus Persistence in Porcine Tonsils Is Associated With a Weak Induction of the Innate Immune Response, an Absence of IFNγ mRNA Expression, and a Decreased Frequency of CD4+CD8+ Double-Positive T Cells.Front Cell Infect Microbiol. 2022 Feb 24;12:834888. doi: 10.3389/fcimb.2022.834888. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35281443 Free PMC article.
-
Blocking HSV-1 glycoprotein K binding to signal peptide peptidase reduces virus infectivity in vitro and in vivo.PLoS Pathog. 2021 Aug 5;17(8):e1009848. doi: 10.1371/journal.ppat.1009848. eCollection 2021 Aug. PLoS Pathog. 2021. PMID: 34352042 Free PMC article.
-
Japanese Encephalitis Vaccines.Curr Treat Options Infect Dis. 2020;12(4):375-386. doi: 10.1007/s40506-020-00242-5. Epub 2020 Nov 12. Curr Treat Options Infect Dis. 2020. PMID: 33204220 Free PMC article. Review.
-
Human T cell responses to Japanese encephalitis virus in health and disease.J Exp Med. 2016 Jun 27;213(7):1331-52. doi: 10.1084/jem.20151517. Epub 2016 May 30. J Exp Med. 2016. PMID: 27242166 Free PMC article. Clinical Trial.
-
Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells.J Virol. 2009 May;83(10):4766-77. doi: 10.1128/JVI.01850-08. Epub 2009 Mar 4. J Virol. 2009. PMID: 19264772 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials